{
    "nct_id": "NCT05254795",
    "official_title": "Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care",
    "inclusion_criteria": "* Clinically suspected or histologically confirmed stage IIb-IV NSCLC who are planning to undergo treatment\n* No prior systemic therapies for NSCLC, with the exception of adjuvant therapy for early stage NSCLC. Prior surgery and/or radiation is allowed.\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 120 Years",
    "exclusion_criteria": "* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with targeted therapy, in the opinion of the treating physician.\n* Pregnancy",
    "miscellaneous_criteria": ""
}